Oxytocin for Complications During Labor

The Role of Oxytocin in the Second Stage of Labor

Recruiting N/A Interventional Study
Labor Complication
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
400 (estimated)
Sponsor
Washington University School of Medicine · Other
Who this trial is looking for

This trial is looking for women who are having their first baby and are 37 weeks or more pregnant. It will investigate the effects of oxytocin during the second stage of labor.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a first-time pregnant woman.
  • I am at least 37 weeks pregnant.
  • I have a single baby.
  • I am admitted for labor induction or natural labor.

You may not be able to join if

  • I am pregnant with more than one baby.
  • I have been pregnant before.
  • I have a serious fetal condition.
  • I am not receiving oxytocin when fully dilated.
  • The baby's head is visible at the time of full dilation.
  • I have a health condition that prevents a long second stage of labor.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Nulliparous pregnant women \>/= 37 weeks gestation * Singleton pregnancies * Admission for induction of labor or spontaneous labor Exclusion Criteria: * Multiple gestations * Multiparous patients * Patients with major fetal anomalies * Not on oxytocin at the time of complete…
Contacts

Nandini Raghuraman, MD MSCI

9186917389

nraghuraman@wustl.edu

CONTACT